| Jeremy J Jerdee, CRNA | |
|
2845 Greenbrier Rd, Green Bay, WI 54311-6519 | |
| (920) 288-3388 | |
| (920) 288-3370 |
| Full Name | Jeremy J Jerdee |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 24 Years |
| Location | 2845 Greenbrier Rd, Green Bay, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053323782 | NPI | - | NPPES |
| 43408000 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 129285 (Wisconsin) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Park Nicollet Methodist Hospital | 7315840063 | 98 |
News Archive
Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.
The study, which is one of the first to look at how fast second-language words are learned and how the brain responds to words with increasing experience with the new language, was published June 13 in the on-line edition of the journal Nature Neuroscience.
Adapting adult medical devices to be used for children is a common but often problematic practice across U.S. hospitals. At the University of Michigan and U-M C.S. Mott Children's Hospital, pediatricians and researchers who care for children have been leading the charge to change this. They work to create, engineer and test medical devices and curb problems that come from using tools, implants, gadgets and procedures designed for adults.
The study, which looked at Medicare records of more than 130,000 women, found that those who underwent the faster treatment, called brachytherapy, were about twice as likely to have a mastectomy in the following five years -;
› Verified 6 days ago
| Entity Name | Park Nicollet Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083622047 PECOS PAC ID: 7315840063 Enrollment ID: O20040129000853 |
News Archive
Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.
The study, which is one of the first to look at how fast second-language words are learned and how the brain responds to words with increasing experience with the new language, was published June 13 in the on-line edition of the journal Nature Neuroscience.
Adapting adult medical devices to be used for children is a common but often problematic practice across U.S. hospitals. At the University of Michigan and U-M C.S. Mott Children's Hospital, pediatricians and researchers who care for children have been leading the charge to change this. They work to create, engineer and test medical devices and curb problems that come from using tools, implants, gadgets and procedures designed for adults.
The study, which looked at Medicare records of more than 130,000 women, found that those who underwent the faster treatment, called brachytherapy, were about twice as likely to have a mastectomy in the following five years -;
› Verified 6 days ago
| Entity Name | Anesthesiology, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013960798 PECOS PAC ID: 9335033034 Enrollment ID: O20040212000459 |
News Archive
Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.
The study, which is one of the first to look at how fast second-language words are learned and how the brain responds to words with increasing experience with the new language, was published June 13 in the on-line edition of the journal Nature Neuroscience.
Adapting adult medical devices to be used for children is a common but often problematic practice across U.S. hospitals. At the University of Michigan and U-M C.S. Mott Children's Hospital, pediatricians and researchers who care for children have been leading the charge to change this. They work to create, engineer and test medical devices and curb problems that come from using tools, implants, gadgets and procedures designed for adults.
The study, which looked at Medicare records of more than 130,000 women, found that those who underwent the faster treatment, called brachytherapy, were about twice as likely to have a mastectomy in the following five years -;
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeremy J Jerdee, CRNA Po Box 8900, 2845 Greenbrier Rd, Green Bay, WI 54308-8900 Ph: (920) 288-3388 | Jeremy J Jerdee, CRNA 2845 Greenbrier Rd, Green Bay, WI 54311-6519 Ph: (920) 288-3388 |
News Archive
Micromet, Inc. today announced the initiation of a phase 2 trial of the Company's lead product candidate blinatumomab (MT103) in adult patients with relapsed or refractory B-precursor acute lymphoblastic leukemia (ALL). Blinatumomab is the first of a new class of agents called BiTE antibodies, designed to harness the body's T cells to kill cancer cells.
The study, which is one of the first to look at how fast second-language words are learned and how the brain responds to words with increasing experience with the new language, was published June 13 in the on-line edition of the journal Nature Neuroscience.
Adapting adult medical devices to be used for children is a common but often problematic practice across U.S. hospitals. At the University of Michigan and U-M C.S. Mott Children's Hospital, pediatricians and researchers who care for children have been leading the charge to change this. They work to create, engineer and test medical devices and curb problems that come from using tools, implants, gadgets and procedures designed for adults.
The study, which looked at Medicare records of more than 130,000 women, found that those who underwent the faster treatment, called brachytherapy, were about twice as likely to have a mastectomy in the following five years -;
› Verified 6 days ago
Mr. Peter B Michon, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2845 Greenbrier Rd, Green Bay, WI 54308 Phone: 920-288-3388 Fax: 920-288-3370 | |
Angela L Mathias, SRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2845 Greenbrier Rd, Green Bay, WI 54311 Phone: 920-288-3388 Fax: 920-288-3370 | |
Julie A Podlasik, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 744 S Webster Ave, Green Bay, WI 54301 Phone: 920-445-7226 Fax: 920-445-7289 | |
Christine M Zasuly, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2845 Greenbrier Rd, Green Bay, WI 54311 Phone: 920-288-3388 Fax: 920-288-3370 | |
Joseph A Wenszell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 744 S Webster Ave, Green Bay, WI 54301 Phone: 920-433-3605 Fax: 920-433-3589 | |
Barbara A. Eland, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 835 S Van Buren St, Green Bay, WI 54301 Phone: 920-433-0111 Fax: 920-431-3071 |